Processa Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2012 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2012 to Q2 2025.
  • Processa Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $203K, a 33.2% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $630K, a 73.5% decline from 2023.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.37M, a 73.1% decline from 2022.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.83M, a 458% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $203K +$50.6K +33.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $228K +$60.1K +35.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q2 2024 $153K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $168K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2019 $510K $116K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-06
Q3 2019 $269K +$219K +433% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $66.5K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $58.6K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
Q3 2018 $50.5K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2016 $28.5K $1.63K -$37.9K -95.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-30
Q1 2016 $66.4K $5.06K -$30.5K -85.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-08-07
Q4 2015 $96.9K $12.8K -$8.92K -41.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-09-25
Q3 2015 $106K $9.1K -$37K -80.3% Jul 1, 2015 Sep 30, 2015 10-Q 2017-09-08
Q2 2015 $143K $39.5K +$5.21K +15.2% Apr 1, 2015 Jun 30, 2015 10-Q 2017-08-30
Q1 2015 $138K $35.6K -$93.9K -72.5% Jan 1, 2015 Mar 31, 2015 10-Q 2017-08-07
Q4 2014 $232K $21.7K -$127K -85.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-06-19
Q3 2014 $359K $46.1K +$28.6K +163% Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-01
Q2 2014 $330K $34.3K +$3.94K +13% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 $326K $129K +$110K +570% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $216K $149K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-14
Q3 2013 $17.5K -$57.7K -76.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $30.4K -$43K -58.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 $19.3K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q3 2012 $75.2K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $73.4K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.